Around one in five women have repeated UTIs – more than two UTIs in six months, or more than three in a year. “You may get a recurrent UTI if the first UTI wasn’t adequately treated,” Dr Nanayakkara ...
PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...
The CDC estimates that six in ten adults in the United States currently live with a chronic disease such as ... is the most common form of cancer among women, which is why the United States ...
The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and ...